Lilly's New Obesity Pill Off to Slow Start in Race With Novo [Yahoo! Finance Canada]
Novo Nordisk A/S (NVO)
Last novo nordisk a/s earnings: 2/5 01:31 am
Check Earnings Report
US:NYSE Investor Relations:
novonordisk.com/investors.html
Company Research
Source: Yahoo! Finance Canada
of the challenge the drugmaker will have as it tries to catch up with rival Novo Nordisk A/S. Most Read from Bloomberg Foundayo generated 3,707 prescriptions in its second week, according to IQVIA data cited by RBC Capital Markets analyst Trung Huynh. For comparison, an oral version of Novo's Wegovy drew 18,410 prescriptions in its second week of launch. Lilly shares fell 2.6% at 9:35 am in New York, while Novo rose 4% in Denmark. Lilly's once-daily pill won US clearance earlier this month under a new program designed to expedite access to promising medications. The approval ratcheted up pressure on Novo, whose rival weight-loss pill — launched in January — has been key to its turnaround efforts. Foundayo is being closely scrutinized by investors who see pills as the next frontier of weight-loss medicine. But until it's been on the market for two to three months, factors such as sampling programs and the difficulty of capturing telehealth prescriptions will make it tougher t
Show less
Read more
Impact Snapshot
Event Time:
NVO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVO alerts
High impacting Novo Nordisk A/S news events
Weekly update
A roundup of the hottest topics
NVO
News
- Lilly's New Obesity Pill Off to Slow Start in Race With Novo [Yahoo! Finance]Yahoo! Finance
- Eli Lilly's new GLP-1 pill vs. Wegovy, JPMorgan initiates coverage on Hims [Yahoo! Finance Canada]Yahoo! Finance Canada
- Lilly's obesity pill hits nearly 4000 prescriptions in second week after launch [Yahoo! Finance]Yahoo! Finance
- Eli Lilly slips as obesity scripts said to trail those for Novo's Wegovy [Seeking Alpha]Seeking Alpha
- Here's Why Agios Pharmaceuticals Stock Slumped This Week (And What Investors Have to Look Forward to in 2026) [Yahoo! Finance]Yahoo! Finance
NVO
Earnings
- 2/3/26 - Beat
NVO
Sec Filings
- 4/20/26 - Form 6-K
- 4/20/26 - Form 6-K
- 4/13/26 - Form 6-K
- NVO's page on the SEC website